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Abstract
Background: Music therapy (MT) has been used as adjunct therapy for schizophrenia for decades. However, its
role is still inconclusive. A recent meta-analysis demonstrated that MT for schizophrenic patients only significantly
benefits negative symptoms and mood symptoms rather than positive symptoms. In addition, the association
between specific characteristics of MT and the treatment effect remains unclear. The aim of this study was to
update the published data and to explore the role of music therapy in adjunct treatment in schizophrenia with a
thorough meta-analysis.
Methods: We compared the treatment effect in schizophrenic patients with standard treatment who did and
did not receive adjunct MT through a meta-analysis, and investigated the clinical characteristics of MT through
meta-regression.
Results: The main finding was that the treatment effect was significantly better in the patients who received
adjunct MT than in those who did not, in negative symptoms, mood symptoms, and also positive symptoms
(all p < 0.05). This significance did not change after dividing the patients into subgroups of different total duration
of MT, amounts of sessions, or frequency of MT. Besides, the treatment effect on the general symptoms was
significantly positively associated with the whole duration of illness, indicating that MT would be beneficial for
schizophrenic patients with a chronic course.
Conclusions: Our meta-analysis highlights a significantly better treatment effect in schizophrenic patients who
received MT than in those who did not, especially in those with a chronic course, regardless of the duration,
frequency, or amounts of sessions of MT. These findings provide evidence that clinicians should apply MT for
schizophrenic patients to alleviate disease severity.
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Background
Schizophrenia is one of the most serious psychiatric dis-
eases worldwide. It causes significant dysfunction in
multi-dimensions of personal function of the patients,
with a wide range of clinical symptoms. In general, the
symptoms of schizophrenia can be classified as positive
symptoms, negative symptoms, and general psychopath-
ology [1]. In addition, patients with schizophrenia also
often have comorbid mood symptoms, either in the form
of a manic mood or depression. Furthermore, risk fac-
tors associated with schizophrenia such as violence and
suicide have been found to be correlated with the spe-
cific symptoms of schizophrenia. Among them, the risk
of violence has been reported to be correlated with posi-
tive symptoms [2], and the risk of suicide has been re-
ported to be correlated with negative symptoms and
mood symptoms [3, 4].
Music therapy has been used in the treatment of
schizophrenia for decades, and it is often used as adjunct
therapy to medication. It can take the format of individ-
ual therapy [5], large group therapy [6], or a combin-
ation of individual and group therapy [7] through either
“passive listening” [8–10] or “active participation” [6, 7].
Every form of music therapy has an effect in schizo-
phrenic patients to a certain extent. However, most stud-
ies investigating the treatment effect of music therapy
have focused on the effect on negative and mood symp-
toms only [6, 7, 9–13].
Recently, there is one huge review article discussing
the clinical application of music therapy in different dis-
ease entity, including neoplasm, disease of central ner-
vous system, psychiatric illness, and so on [14]. In this
article, the authors reviewed the evidences of music
therapy in the schizophrenic patients mainly according
to one recent meta-analysis conducted by the Mössler
and the colleagues (2011) [15]. In this meta-analysis con-
ducted by Mössler and the colleagues, the authors sug-
gested that the application of music therapy in
schizophrenic patients would be beneficial with regards
to negative symptoms and mood symptoms. On the
other hand, because of a lack of evidence, the role of
music therapy in the treatment of positive symptoms in
schizophrenic patients is inconclusive. However, positive
symptoms have been proven to be highly associated with
the risk of violence [2], which contributes to the
stigmatization of patients with schizophrenia [16]. Fur-
thermore, the report by Mössler et al. (2011) did not
provide further information about the association be-
tween the treatment effect of music therapy and the spe-
cific characteristics of music therapy applied in
schizophrenic patients.
In order to explore (1) the treatment effect of music
therapy in patients with schizophrenia, and (2) the role
of specific characteristics of music therapy in the
treatment effect, we conducted this meta-analysis to
evaluate the treatment effect of music therapy on the
specific subscale symptoms of schizophrenia, including
the overall disease severity of schizophrenia, positive
symptoms, negative symptoms, general psychopathology,
and mood symptoms. We performed meta-regression
analysis to evaluate the association between the treat-
ment effect of music therapy and the clinical variables or
specific characteristics of music therapy, including fre-
quency, duration of each session, total number of ses-
sions of music therapy, and total duration of music
therapy.
Methods
Database schema and implementation
A systematic literature search was conducted by two in-
dependent psychiatrists (Wang, H.Y. and Tu, K.Y.)
through PubMed. If there was an inconsistent selection
and lack of agreement, a final decision was made by con-
sensus. The search was performed using the key words
“(music therapy) AND (schizophrenia)” for all articles
written in English available unto September 10th, 2015.
Initially, all of the search results meeting the inclusion
criteria were collected, and the titles and abstracts were
screened by Wang, H.Y. and Tu, K.Y. When there was
disagreement on eligibility, we reached agreement
through consensus. In current study protocol, the defin-
ition of music therapy had two forms of definition; the
wide definition was that all the music applied in the
treatment of patients, and the narrow one was that the
music therapy should be arranged under specific set-
tings, for example, group therapy, individual therapy, ac-
tive participation, or directed by a specialists. All studies
that were not related to music therapy in schizophrenic
patients were excluded. Using the following inclusion
criteria, we thoroughly screened the studies: (1) articles
discussing comparisons of the treatment effect in pa-
tients with schizophrenia treated with music therapy and
those with/without placebo; (2) articles on clinical trials
in humans; and (3) case-controlled trials, either random-
ized or non-randomized. The exclusion criteria were (1)
case reports or series; and (2) non-clinical trials. The
screening and search protocol is shown in Fig. 1. We
used Jadad scores to investigate the quality of the clinical
trials included in this meta-analysis [17].
Data extraction
The primary outcome was disease severity rating scale,
which varied in every study and included the Brief Psy-
chiatric Rating Scales (BPRS) [18] , the Positive And
Negative Symptoms Scales (PANSS) [1], the Scale for
the Assessment of Negative Symptoms (SANS) [19], and
the Self-rating Depression Scales (SDS) [20]. All of the
primary outcomes and other clinical variables were
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extracted from all of the studies included in the current
meta-analysis. When data were not available, we tried to
contact the authors to acquire the original data. Among
the rating scales, we gave priority to the PANSS rather
than the BPRS, SANS, and SDS, because it is more spe-
cific to the setting of schizophrenia.
Meta-analytic methods and quality of control
All of the effect sizes (ESs), which indicated changes in
disease severity rating scales in the included studies,
were set as the standardized mean difference based on
Hedges’ adjusted g. We defined an ES greater than 0 as
indicating “greater improvements in the primary out-
come in schizophrenic patients who received music ther-
apy than in patients treated with/without a placebo”. We
tried to derive the ESs from other statistical parameters
such as the t or p value with the sample size when the
disease severity rating scales or the original data from
the authors were unavailable. All of the ESs were synthe-
sized using a random effects model for every meta-
analysis.
All of the meta-analytic procedures were performed
using Comprehensive Meta-Analysis software, version 2
(Biostat, Englewood, NJ, USA). We considered the
analysis to be statistically significant when a two-tailed p
value was <0.05. We used Q statistics, their related p-
value, and the I2 statistic to investigate the heterogeneity
of each study. We investigated publication bias through
funnel plots, and Egger’s regression analysis was used to
test statistically for the significance of any possible publi-
cation bias [21]. We also performed subgroup meta-
analysis or meta-regression analysis using the unre-
stricted maximum likelihood method to examine pos-
sible sources of heterogeneity and to investigate the
possible confounding effects of clinical variables such as
age, gender, duration of illness, number of previous hos-
pitalizations, chlorpromazine equivalence, frequency of
music therapy, total duration of music therapy, total
number of sessions of music therapy, duration of each
session of music therapy, disease severity, and “whole
duration of illness”. We defined whole duration of illness
as the period from the onset of psychosis to the time
when the patients entered the study. Furthermore, we
performed subgroup meta-analysis of positive symptoms,
negative symptoms, general psychopathology, and mood
symptoms for the treatment effect of music therapy. In
addition, to investigate whether or not the study design
contributed to a different treatment effect, we performed
Fig. 1 Flowchart of the selection strategy and inclusion/exclusion criteria for the current meta-analysis
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subgroup meta-analysis to evaluate the treatment effect
of music therapy in trials with randomized control trials
(RCTs) or non-randomized control trials (non-RCTs).
Besides, we also perform subgroup meta-analysis to in-
vestigate the possible confounding effect of different
strategy of music therapy on the treatment effect. These
meta-analytic procedures fulfilled the criteria of Preferred
Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) (Additional file 1) [22]. About the ethics of
current study, it was not necessary for the ethical approval
because that we would not deal with the patients’ detailed
data. Furthermore, it was impossible for us to contact all
the patients for the informed consent.
Results
Studies included in each meta-analysis
After screening, a total of 12 articles remained for meta-
analysis (Table 1) [5–7, 9–13, 23–26]. One of these stud-
ies used the SDS only which is less specific to the disease
severity of schizophrenia [10], and thus we included this
study in the meta-analysis of the treatment effect of
music therapy on the mood symptoms of schizophrenic
patients only. The quality of the clinical trials was rated
with an average Jadad score of 1.58 (Additional file 2:
Table S1).
The main results of the current meta-analysis
After the screening procedure, no reports used a placebo
in the control group, and none of the subjects were
drug-free. Therefore, in the meta-analysis, we included
studies that compared the treatment effect in schizo-
phrenic patients receiving the standard treatment with
adjunctive music therapy and those without adjunctive
music therapy. A total of 402 schizophrenic patients
who received adjunct music therapy and 402 who did
not were extracted from the 12 studies. The treatment
effect in the schizophrenic patients was significantly bet-
ter in those treated with adjunct music therapy than in
those treated without adjunct music therapy (ES = 3.25,
95 % confidence interval (CI): 2.08 to 4.42, p < 0.001)
(Fig. 2a). Significant heterogeneity within these studies
was found (Q = 498.7, df = 12, I2 = 97.6 %, p < 0.001). In
addition, significant publication bias was detected using
Egger’s test (t = 7.25, df = 11, 2-tailed p < 0.001) and in
visual examination of the funnel plot. Furthermore, in
subgroup meta-analysis of the different trial designs, we
found a significantly better treatment effect in the
schizophrenic patients who received adjunct music ther-
apy than in those who did not in both non-RCT and
RCT subgroups (ESs = 1.64, 95 % CI: 0.25 to 3.03, p =
0.021; ESs = 4.49, 95 % CI: 2.76 to 6.23, p < 0.001, re-
spectively) (Fig. 2b).
We then used meta-regression analysis to investigate
any possible confounding clinical variables within the
studies. The results revealed that only the whole dur-
ation of illness and the number of previous hospitaliza-
tions were significantly associated with the treatment
effect (slope = 3.30, p < 0.001; slope = −3.65, p = 0.04, re-
spectively), but not mean age, gender (female propor-
tion), frequency of music therapy, total duration of
music therapy, duration of each session of music ther-
apy, total number of sessions of music therapy, and
chlorpromazine equivalence (p = 0.71, 0.40, 0.82, 0.36,
0.58, 0.79, and 0.46, respectively) (Table 2).
We then investigated whether or not music therapy
was beneficial in any subset of psychiatric or mood
symptoms. The results showed that music therapy im-
proved positive symptoms (ES = 1.63, 95 % CI: 0.30 to
2.96, p = 0.017) (Fig. 3 (a)), negative symptoms (ES =
4.14, 95 % CI: 2.54 to 5.74, p < 0.001) (Fig. 3 (b)), and
mood symptoms (ES = 1.00, 95 % CI: 0.56 to 1.43, p <
0.001) (Fig. 3 (c)), but not the subscales of general psy-
chopathology (ES = 9.30, 95 % CI: −0.68 to 19.28, p =
0.068). We did not find any differences in dropout rate
between the patients who did and did not receive ad-
junct music therapy (ES = −0.08, 95 % CI: −0.35 to 0.19,
p = 0.574).
The main results of subgroup meta-analysis in the dur-
ation of each session of music therapy
Although there was no significant association between
the treatment effect of music therapy and the duration
of each session of music therapy, we performed sub-
group analysis by separating the included studies into
those with a duration of less than 1 h [5, 11, 13, 24, 26]
and those with a duration of 1 h or longer [6, 7, 23, 25].
The results revealed that both subgroups were associated
with significantly better treatment effects in the patients
who received adjunct music therapy than in those who
did not (ES = 2.00, 95 % CI: 0.70 to 3.31, p = 0.003; ES =
7.62, 95 % CI: 4.66 to 10.58, p < 0.001, respectively)
(Table 3).
The main results of subgroup meta-analysis in the total
duration of music therapy
Similarly, we performed subgroup analysis by separating
the included studies into those with a total duration of
music therapy shorter than 3 months [6, 9, 12, 13, 23,
24, 26] and those with a total duration of 3 months or
longer [5, 7, 11, 25] according to guidelines used in a
previous report [15]. The results revealed that both sub-
groups were associated with a significantly better treat-
ment effect in the patients who received adjunct music
therapy than in those who did not (ES = 3.97, 95 % CI:
2.03 to 5.91, p < 0.001; ES = 3.00, 95 % CI: 1.36 to 4.64,
p < 0.001, respectively) (Table 3).
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Table 1 Summary of characteristics of studies in current meta-analysis
Study Diagnostic
criteria































































































































































33.5 ± 8.0 19.7 531.0 ± 226.4 n/a SANS negative symptoms Prospective,
SB, RCT
China
Data presentation: mean ± SD
Abbreviation: SD standard deviation, n/a not available, DSM-IV diagnostic and statistical manual of mental disorders, 4th Edition, DSM-IV-TR diagnostic and statistical manual of mental disorders, 4th edition, text
revision, DSM-III-R diagnostic and statistical manual of mental disorders, 3rd edition, revision, ICD-10 international classification of disease, 10th edition, CCMD-2 chinese classification of mental disorders, 2nd edition,
CCMD-3, chinese classification of mental disorders, 3rd edition, SADS schedule for affective disorders and schizophrenia, PANSS positive and negative syndrome scales, BPRS brief psychiatric rating scales, SANS schedule











The main results of subgroup meta-analysis in the fre-
quency of music therapy
We then performed subgroup analysis by separating the
included studies into those with a frequency of music
therapy less than 4 times per week [5, 11, 13, 23, 25, 26]
and those with a frequency of 4 times or more per week
[6, 7, 9, 12, 24], because of the significant positive
association between the treatment effect of music ther-
apy and the frequency of music therapy. Both frequen-
cies provided a significantly better treatment effect in
the schizophrenic patients who received adjunct music
therapy than in those who did not (ES = 3.40, 95 % CI:
1.86 to 4.93, p < 0.001; ES = 3.13, 95 % CI: 0.95 to 5.31,
p = 0.005, respectively) (Table 3).
The main results of subgroup meta-analysis in the total
number of sessions of music therapy
We then performed subgroup analysis by separating the
included studies into those with less than 20 sessions in
total [5, 6, 13, 23–26] and with 20 sessions or more [7,
9, 11, 12] according to a previous report [15]. The re-
sults revealed that both subgroups were associated with
a significantly better treatment effect in the patients who
received adjunct music therapy than in those who did
Fig. 2 a. Forest plot showing effect sizes (Hedges’ g) and 95 % confidence intervals (CIs) from individual studies and pooled results of all included
studies comparing total psychopathology between patients with schizophrenia receiving music therapy (MT) and those who did not receive
music therapy (Ctr); b. Forest plot showing effect sizes (Hedges’ g) and 95 % CIs from individual studies and pooled results comparing total
psychopathology between patients with schizophrenia receiving MT and the Ctr group by trial design, such as non-randomized control trials
(non-RCT) and randomized control trials (RCT). *subscales in the report by Hayashi (2002): positive symptoms (p), negative symptoms (n), and
general psychopathology (p). a The treatment effect was better in the MT group than in the Ctr group (p < .001). b The treatment effect was
better in the MT group than in the Ctr group in both non-RCT and RCT subgroups (p = .021 and < .001, respectively). Abbreviation: MA: meta-analysis;
CI: confidence interval; MT: music therapy; Ctr: control groups as schizophrenic patients without music therapy; DSM-IV: Diagnostic and Statistical
Manual of Mental Disorders, 4th Edition; DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision; DSM-III-R:
Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revision; ICD-10: international classification of disease, 10th edition; CCMD-2: Chinese
Classification of Mental Disorders, 2nd edition; CCMD-3: Chinese Classification of Mental Disorders, 3rd edition; SADS: Schedule for Affective Disorders
and Schizophrenia; PANSS: positive and negative syndrome scales; BPRS: brief psychiatric rating scales; SANS: Schedule for Assessment of Negative
Symptoms; RCT: Randomized Controlled Trials; non-RCT: non Randomized Controlled Trials
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not (ES = 3.92, 95 % CI: 2.32 to 5.52, p < 0.001; ES = 2.33,
95 % CI: 0.50 to 4.17, p = 0.013, respectively) (Table 3).
The main results of the subgroup meta-analysis of those
with different subgroups of disease severity
We then subdivided the studies according to their mean
scores of disease severity, either in the PANSS or BPRS.
The criteria of disease severity were based on the report
by Leucht et al. [27, 28], which defined “mildly ill” as a
PANSS score of 58 or BPRS 31, “moderately ill” as
PANSS 75 or BPRS 41, and “severely ill” as PANSS 95 or
BPRS 53. In the current meta-analysis, only one study
recruited schizophrenic patients with severe disease se-
verity [25], one with moderate disease severity [12], and
another two with unknown disease severity which did
not provide definite scores of the rating scales [6, 11].
All of the other reports included subjects with mild dis-
ease severity. Therefore, we could only perform sub-
group meta-analysis in those with mild disease severity
[5, 7, 13, 23, 24, 26]. However, the results still revealed a
significantly better treatment effect (ES = 7.34, 95 % CI:
4.50 to 10.18, p < 0.001) (Table 3).
The main results of the subgroup meta-analysis of
different strategy of music therapy
We then subdivided the studies according to the strategy
of music therapy applied in their studies. At first, we
subdivided them according to forms of music therapy,
including forms of group therapy [6, 9, 10, 12, 13, 23–
26], individual therapy [5, 11], or both [7]. Therefore, we
could perform subgroup meta-analysis only in subgroup
of forms of group therapy, which revealed similar results
(ES = 3.62, 95 % CI: 2.21 to 5.02, p < 0.001). In the other
hand, we subdivided them according to the activities in
the sessions of music therapy, including those with
active participation only, passive listening only [6, 7], or
both [5, 9–13, 23–26]. Therefore, we could perform sub-
group meta-analysis only in subgroup of studies using
sessions of music therapy including both active partici-
pation and passively listening, which revealed similar re-
sults again (ES = 2.26, 95 % CI: 1.20 to 3.32, p < 0.001).
Discussion
The results of this meta-analysis indicated that adjunct
music therapy to standard treatment was associated with
a significantly better treatment effect in schizophrenic
patients than control patients, not only in negative or
mood symptoms but also in positive symptoms. In
addition, this treatment effect was significantly positively
associated with the whole duration of illness, and signifi-
cantly inversely associated with the number of previous
hospitalizations.
In general, the results of this study are consistent with
the previous meta-analysis conducted by Mössler et al.
(2011) [15], which report moderate to large effects in
general mental state, negative symptoms, depression,
and anxiety. In addition, the current meta-analysis pro-
vides additional information to the current knowledge
about the benefits of adjunct music therapy for patients
with schizophrenia, which provided the evidences of the
significant treatment effect of adjunctive music therapy
on the positive symptoms, negative symptoms, and
mood symptoms. In the meta-analysis conducted by
Mössler et al. (2011), the treatment effect of music ther-
apy on positive symptoms was inconclusive because of
limited evidence. In recent years, several new trials and
studies have been published [11, 23, 24]. Among them,
most studies discussed the significantly better treatment
effect of adjunct music therapy on the positive symp-
toms in schizophrenic patients [23, 24]. The significantly
better treatment effect in newer published studies rather
than previous reports might be derived from the differ-
ent intervention design (group therapy versus individual
therapy) [5, 23], different frequency of music therapy
[24, 25], or different total duration of music therapy [5,
24]. Thus, it is necessary to conduct a further meta-
analysis based on these newer evidences. The clinical
implication that adjunct music therapy can alleviate
positive symptoms in schizophrenic patients more effect-
ively than in those who do not receive adjunct music
therapy is important, in particular because positive
symptoms are thought to be highly associated with the
risk of violence [2]. In addition, Courtright P and the
colleague (1990) reported that the use of music therapy
could help in reducing aggressive behavior in schizo-
phrenic patients [29]. Among the positive symptoms, the
hallucination and delusion had been thought to be more
prominent in clinical practice. Furthermore, the relation-
ship between the auditory hallucination and music
Table 2 Result of meta-regression of clinical variables and
characters of MT with the treatment effect of adjunct MT in
schizophrenic patients
Items slope p value
Mean age 0.11 0.712
female proportion −0.10 0.404
Frequency of MT −0.44 0.822
Total duration of MT −0.73 0.362
Duration of each session of MT 6.61 0.576
Total number of sessions of MT −0.06 0.789
Whole duration of illness*** 3.30 <0.001
Chlorpromazine equivalence −0.04 0.456
Number of previous hospitalization* −3.65 0.040
Meta-regression with unrestricted maximum likelihood method
*: p < 0.05
***: p < 0.001
Abbreviation: MT: music therapy
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therapy was also one of the interesting topics about
the treatment effect of adjunct music therapy in
schizophrenic patients. However, we could not per-
form such meta-analysis of these topics because of
the limited reports providing these data [7, 24].
Among these articles, there was only one discussing
the differences of severity of hallucination or delu-
sion after treatment of adjunct music therapy [7]
and only one comparing the changes of severity of
hallucination or delusion between experiment group
(patients with adjunct music therapy) and control
group (patients with standard treatment only) [24].
When we investigated the results of these two stud-
ies, we found significantly lower severity of hallucin-
ation and delusion after treatment of adjunct music
therapy and significantly better improvement in hal-
lucination in patients with adjunct music therapy
than those with standard treatment only but not in
delusion.
We also performed meta-regression analysis to evalu-
ate the possible confounding effect of clinical variables.
The results showed that the treatment effect of music
therapy was positively associated with the “whole dur-
ation of illness”. This means that the application of
music therapy for schizophrenic patients could alleviate
disease severity, especially in those with chronic illness.
Several authors have investigated the effect of music
therapy on cognitive function in patients with chronic
schizophrenia, and reported significant benefits [30]. In
addition, the usage of specific music therapy has been
Fig. 3 Forest plot showing effect sizes (Hedges’ g) and 95 % confident intervals (CIs) from individual studies and pooled results
comparing a. positive symptoms, b. negative symptoms, and c. mood symptoms between schizophrenic patients who received music
therapy (MT) and those who did not (Ctr). a The treatment effect was better in the MT group compared to the Ctr group in subscales
of positive symptoms (p = .017). b. The treatment effect was better in the MT group compared to the Ctr group in subscales of negative
symptoms (p < .001). c. The treatment effect was better in the MT group compared to the Ctr group in subscales of mood symptoms
(p < .001). Abbreviation: MA: meta-analysis; CI: confidence interval; MT: music therapy; Ctr: control groups as schizophrenic patients without
music therapy; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; DSM-IV-TR: Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition, Text Revision; DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revision; ICD-10:
international classification of disease, 10th edition; CCMD-2: Chinese Classification of Mental Disorders, 2nd edition; CCMD-3: Chinese
Classification of Mental Disorders, 3rd edition; SADS: Schedule for Affective Disorders and Schizophrenia; PANSS: positive and negative
syndrome scales; BPRS: brief psychiatric rating scales; SANS: Schedule for Assessment of Negative Symptoms; CDSS: depression scale for
schizophrenia; SDS: Self-rating Depression Scales; HAM-D: Hamilton rating scale for depression
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reported to improve attention and motor performance
in chronic schizophrenic patients [8, 31, 32]. Taken to-
gether, supplemental music therapy can provide signifi-
cant benefits for schizophrenic patients with a chronic
course with regards to disease severity and also cognitive
function.
In this study, we found a significantly inverse associ-
ation between the treatment effect of music therapy and
the number of previous hospitalizations. This seems to
be in contrast to our other finding of a positive associ-
ation between the treatment effect of music therapy and
the whole duration of illness. A possible explanation
may be the specific characteristics of the patients with
more previous hospitalizations. In previous reports,
schizophrenic patients with more previous hospitaliza-
tions have been reported to have worse treatment adher-
ence, poorer treatment attitude, easier relapse, and poor
support systems [33–35]. Therefore, the adherence or at-
tendance rate to music therapy in schizophrenic patients
with more previous hospitalizations may be poorer than
those with fewer previous hospitalizations. However, we
could not investigate the association between adherence/
attendance rate and the treatment effect of music ther-
apy because of a lack of data.
With regards to safety profile, the dropout rate was
not significantly different between the schizophrenic pa-
tients who did and not receive adjunct music therapy. In
addition, when we investigated the included studies indi-
vidually, no severe adverse effect profile was reported
with the use of music therapy.
With regards to the cost-effectiveness of music therapy
in the treatment of schizophrenic patients, we found no
significant associations between the treatment effect of
music therapy and the frequency of music therapy, the
total duration of music therapy, and the duration of each
session of music therapy in meta-regression analysis.
Furthermore, we investigated whether there was any dif-
ference in the treatment effect of adjunct music therapy
in subgroup analysis by different frequency of music
therapy or different total duration of music therapy. The
results showed that the treatment effect was significantly
better compared to those who did not receive adjunct
music therapy, both in a total duration of music therapy
shorter than 3 months and 3 months or longer, and a
frequency of less than 4 times per week and 4 times a
week or more. This indicates that adjunct music therapy
in schizophrenic patients can result in a better treatment
effect compared to those who do not receive adjunct
music therapy when introduced into a treatment pro-
gram regardless of the total duration, frequency, or dur-
ation of each session of music therapy. Because music
therapy is costly and complex, clinicians may be reluc-
tant to include it in clinical practice. However, our find-
ings show that the effect of music therapy is beneficial
regardless of the frequency, length, and duration. There-
fore, we suggest that clinicians should consider including
adjunct music therapy into their clinical practice to pro-
vide their patients with the best outcomes possible.
Limitation
There are some limitations to the current meta-analysis.
First, most of the included studies conducted adjunct
music therapy as a combination of passive listening and
active participation and most of them were performed in
forms of group therapy. This may lead to the problem
that, for most of the studies that involved playing music,
the therapy group would likely consist of patients who
knew how to play an instrument. However, in the real
world, this situation is unlikely to occur. Further studies
are needed to investigate whether “passive listening” or
“individual therapy” can provide benefits for schizo-
phrenic patients, either in disease severity or with other
Table 3 Result of subgroup meta-analysis of the treatment effect of adjunct MT in schizophrenic patients
Subgroup MA Effect
sizes
95 % confidence interval p value
Lower limit Upper limit
Duration of each session of MT <1 h 2.00 0.70 3.31 0.003
> or = 1 h 7.62 4.66 10.58 <0.001
Total duration of MT <3 months 3.97 2.03 5.91 <0.001
> or = 3 months 3.00 1.36 4.64 <0.001
Frequency of MT <4 times/week 3.40 1.86 4.93 <0.001
> or = 4 times/week 3.13 0.95 5.31 0.005
Total number of sessions of MT <20 sessions 3.92 2.32 5.52 <0.001
> or = 20 session 2.33 0.50 4.17 0.013
Different disease severity Mild 7.34 4.50 10.18 <0.001
Moderate n/a n/a n/a n/a
Severe n/a n/a n/a n/a
Abbreviation: MT music therapy, MA meta-analysis, n/a no applicable
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symptoms. Second, as mentioned in the Discussion, we
could not further analyze the association between the
treatment effect of music therapy and the attendance
rate of music therapy because of a lack of data. However,
the attendance rate may be a confounding effect on the
treatment effect of music therapy. Third, in order to per-
form the meta-analysis for the treatment effect of music
therapy on the general aspect of disease severity, positive
symptoms, negative symptoms, general psychopathology,
and mood symptoms, we pooled different studies with
different rating scales including the PANSS, BPRS,
SANS, and SDS. This may have increased the heterogen-
eity in the meta-analysis, which achieved significance.
However, in previous reports, disease severity was shown
to be associated between different rating scales to some
degree [27, 28]. In addition, there were no absolute con-
traindications to pool these different rating scales to-
gether. Therefore, in order thoroughly meta-analyze the
subscales of specific symptoms, we chose to pool those
rating scales together. Besides, in current study, we
could not perform detailed meta-analysis of treatment
effect of adjunct music therapy for the specific symp-
toms, such as hallucination or delusion, because of the
limited reports providing such information. Finally, we
tried to investigate the treatment effect of music therapy
on schizophrenic patients with different disease severity.
However, we could only perform the meta-analysis on
those with mild disease severity but not those with mod-
erate or severe disease severity because of a lack of suffi-
cient trials.
Conclusion
Our meta-analysis provides strong evidence to prove the
role of adjunct music therapy in the treatment of schizo-
phrenic patients. In these patients, adjunct music ther-
apy improved the effect of treatment in negative and
mood symptoms, and also positive symptoms compared
to those who did not receive music therapy regardless of
the total duration, frequency, total number of sessions,
or the duration of each session of music therapy. The ef-
fect of treatment was especially pronounced for those
with a chronic disease course. However, in order to ex-
tensively apply adjunct music therapy in a clinical set-
ting, further trials are needed to evaluate the treatment
effect of music therapy with “passive listening,” the pos-
sible confounding effect of attendance rate, and the
treatment effect of music therapy on those with moder-
ate or severe disease severity.
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